Marrone Bio Innovations Inc logo

MBII - Marrone Bio Innovations Inc Share Price

$2.24 -0.0  -0.4%

Last Trade - 05/03/21

Sector
Basic Materials
Size
Small Cap
Market Cap £271.0m
Enterprise Value £282.6m
Revenue £27.0m
Position in Universe 3755th / 6651
Bullish
Bearish
Unlock MBII Revenue
Momentum
Relative Strength (%)
1m +16.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -22.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
9.14 9.80 14.0 18.2 21.2 29.4 39.7 54.6 +26.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, MarroneBio Innovations Inc revenues increased 35% to $30.7M. Netloss decreased 41% to $16M. Revenues reflect Licenseincrease of 7% to $361K. Lower net loss reflects Loss onissuance of new warrants decrease of 71% to $1.4M (expense), Research and development decrease of 16% to $8.7M(expense), Loss on modification of warrants decrease from$1.6M (expense) to $0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MBII Revenue Unlock MBII Revenue

Net Income

MBII Net Income Unlock MBII Revenue

Normalised EPS

MBII Normalised EPS Unlock MBII Revenue

PE Ratio Range

MBII PE Ratio Range Unlock MBII Revenue

Dividend Yield Range

MBII Dividend Yield Range Unlock MBII Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MBII EPS Forecasts Unlock MBII Revenue
Profile Summary

Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated June 15, 2006
Public Since August 2, 2013
No. of Shareholders: 80
No. of Employees: 113
Sector Basic Materials
Industry Chemicals
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 167,478,301
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MBII Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MBII
Upcoming Events for MBII
Frequently Asked Questions for Marrone Bio Innovations Inc
What is the Marrone Bio Innovations Inc share price?

As of 05/03/21, shares in Marrone Bio Innovations Inc are trading at $2.24, giving the company a market capitalisation of £271.0m. This share price information is delayed by 15 minutes.

How has the Marrone Bio Innovations Inc share price performed this year?

Shares in Marrone Bio Innovations Inc are currently trading at $2.24 and the price has moved by 0.115k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Marrone Bio Innovations Inc price has moved by 69.88% over the past year.

What are the analyst and broker recommendations for Marrone Bio Innovations Inc?

Of the analysts with advisory recommendations for Marrone Bio Innovations Inc, there are there are currently 2 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Marrone Bio Innovations Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Marrone Bio Innovations Inc next release its financial results?

Marrone Bio Innovations Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Marrone Bio Innovations Inc dividend yield?

Marrone Bio Innovations Inc does not currently pay a dividend.

Does Marrone Bio Innovations Inc pay a dividend?

Marrone Bio Innovations Inc does not currently pay a dividend.

When does Marrone Bio Innovations Inc next pay dividends?

Marrone Bio Innovations Inc does not currently pay a dividend.

How do I buy Marrone Bio Innovations Inc shares?

To buy shares in Marrone Bio Innovations Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Marrone Bio Innovations Inc?

Shares in Marrone Bio Innovations Inc are currently trading at $2.24, giving the company a market capitalisation of £271.0m.

Where are Marrone Bio Innovations Inc shares listed? Where are Marrone Bio Innovations Inc shares listed?

Here are the trading details for Marrone Bio Innovations Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: MBII
What kind of share is Marrone Bio Innovations Inc?

Based on an overall assessment of its quality, value and momentum, Marrone Bio Innovations Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Marrone Bio Innovations Inc share price forecast 2021?

Shares in Marrone Bio Innovations Inc are currently priced at $2.24. At that level they are trading at 14.73% discount to the analyst consensus target price of 0.00.

Analysts covering Marrone Bio Innovations Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.152 for the next financial year.

How can I tell whether the Marrone Bio Innovations Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Marrone Bio Innovations Inc. Over the past six months, the relative strength of its shares against the market has been 63.67%. At the current price of $2.24, shares in Marrone Bio Innovations Inc are trading at 65.36% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Marrone Bio Innovations Inc PE Ratio?

We were not able to find PE ratio data for Marrone Bio Innovations Inc.

Who are the key directors of Marrone Bio Innovations Inc?

Marrone Bio Innovations Inc's management team is headed by:

Pamela Marrone - DRC
Keith Pitts - SVP
Linda Moore - EVP
Zachary Wochok - IND
Amit Vasavada - SVP
Timothy Johnson - VPR
Robert Woods - CHM
Yogesh Mago - IND
Kevin Hammill - OTH
Keith McGovern - IND
Kevin Helash - CEO
Lara Lee - DRC
Suping Cheung - CFO
Who are the major shareholders of Marrone Bio Innovations Inc?

Here are the top five shareholders of Marrone Bio Innovations Inc based on the size of their shareholding:

Ospraie Management, L.P. Hedge Fund
Percentage owned: 37.63% (63.0m shares)
Ivy Investment Management Company Investment Advisor
Percentage owned: 15.87% (26.6m shares)
Ivy Science and Technology Fund Mutual Fund
Percentage owned: 15.13% (25.3m shares)
Ardsley Advisory Partners LP Hedge Fund
Percentage owned: 9.52% (16.0m shares)
Van Herk Investments Investment Advisor
Percentage owned: 4.04% (6.76m shares)
Similar to MBII
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.